Glucophage Provision In HR 2887 Could Be Breach Of Contract – Bristol
Executive Summary
A recent Supreme Court ruling related to the savings & loan industry bailout could serve as a precedent for legal challenges by Bristol-Myers Squibb to the Glucophage provision in the pediatric exclusivity reauthorization legislation